Upload
bailey
View
54
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Regional update of the Eastern Mediterranean Region. 12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC -10-11 September , 2013. Dr Nadia Teleb , Regional Adviser, Vaccine Preventable D iseases and Immunization WHO/EMRO. - PowerPoint PPT Presentation
Citation preview
http://www.emro.who.int/entity/vpi/
Regional update of the Eastern Mediterranean Region
12th Annual Meeting of The Measles & Rubella InitiativeAmerican Red Cross, Washington, DC -10-11 September , 2013
Dr Nadia Teleb, Regional Adviser, Vaccine Preventable Diseases and Immunization
WHO/EMRO
http://www.emro.who.int/entity/vpi/
Regional Measles and Rubella Goals
•Measles elimination from all countries by
2015
– Resolution EM/RC44/R.6 – 1997 (elimination by 2010),
revised by Resolution EM/RC58/R.5 – 2011 (elimination
by 2015)
• No regional target for rubella/CRS elimination2
http://www.emro.who.int/entity/vpi/
90% Reduction in Reported Measles CasesReported measles cases and MCV1 coverage, Eastern Mediterranean Region, 1980-2012
3
19801982
19841986
19881990
19921994
19961998
20002002
20042006
20082010
20120
50000
100000
150000
200000
250000
300000
350000
400000
450000
500000
0
10
20
30
40
50
60
70
80
90
100
Measles cases Measles coverage (WHO-UNICEF estimate)
http://www.emro.who.int/entity/vpi/
Palestine
Bahrain
MCV2 introduction into routine EPI in Countries of the EMR 2012
MCV2 introduction into routine EPI in Countries of the EMR 2012
Routine MCV2 introduced
No plan for routine MCV2 introduction
http://www.emro.who.int/entity/vpi/
0
10
20
30
40
50
60
70
80
90
100
Co
vera
ge
%
MCV1 MCV2Source: MCV1: WHO UNICEF estimates MCV2: reported JRF 5
Routine measles vaccination, 2012
http://www.emro.who.int/entity/vpi/
Palestine
Bahrain
Nation-wide Measles-rubella Case-based surveillance (20)
Moving to Nation-wide measles surveillance (1)
Measles Case-Based Surveillance in EMR, 2012
Sentinel site measles surveillance (2)
http://www.emro.who.int/entity/vpi/
Jan-
06Fe
b-06
Mar
-06
Apr-
06M
ay-0
6Ju
n-06
Jul-0
6Au
g-06
Sep-
06O
ct-0
6N
ov-0
6D
ec-0
6Ja
n-07
Feb-
07M
ar-0
7Ap
r-07
May
-07
Jun-
07Ju
l-07
Aug-
07Se
p-07
Oct
-07
Nov
-07
Dec
-07
Jan-
08Fe
b-08
Mar
-08
Apr-
08M
ay-0
8Ju
n-08
Jul-0
8Au
g-08
Sep-
08O
ct-0
8N
ov-0
8D
ec-0
8Ja
n-09
Feb-
09M
ar-0
9Ap
r-09
May
-09
Jun-
09Ju
l-09
Aug-
09Se
p-09
Oct
-09
Nov
-09
Dec
-09
Jan-
10Fe
b-10
Mar
-10
Apr-
10M
ay-1
0Ju
n-10
Jul-1
0Au
g-10
Sep-
10O
ct-1
0N
ov-1
0D
ec-1
0Ja
n-11
Feb-
11M
ar-1
1Ap
r-11
May
-11
Jun-
11Ju
l-11
Aug-
11Se
p-11
Oct
-11
Nov
-11
Dec
-11
Jan-
12Fe
b-12
Mar
-12
Apr-
12M
ay-1
2Ju
n-12
Jul-1
2Au
g-12
Sep-
12O
ct-1
2N
ov-1
2D
ec-1
2Ja
n-13
Feb-
13M
ar-1
3Ap
r-13
May
-13
Jun-
13
2006 2007 2008 2009 2010 2011 2012 2013
0
500
1000
1500
2000
2500
3000
3500
4000
Monthly distribution of confirmed Measles cases in the EMR 2006-June 2013
South SudanSyriaSomaliaQatarPalestinePakistanMoroccoKuwaitJordanBahrain
Confi
rmed
mea
sles
cas
es
11,183
6,4596,079
3,0814,983
13,348
12,347
23,451
http://www.emro.who.int/entity/vpi/
Situation of Rubella
http://www.emro.who.int/entity/vpi/
Palestine
Bahrain
Rubella vaccine planned 2015-2016 (Djibouti)
Rubella vaccine use in countries of the EMR, 2013
9
Rubella vaccine planned 2014 (Yemen)Rubella vaccine in use (16 country)
Rubella vaccine introduction not decided (5 countries)
http://www.emro.who.int/entity/vpi/10
Tunisia
Qatar
Sudan
Yemen
Pakist
an
Kuwait
Afghan
istan
Bahrai
n
South Su
dan UAEOman Ira
q
Saudi A
rabia
Egyp
tIra
n
Jordan
Palesti
ne
Leban
onLib
ya
Morocco Sy
ria
Djibouti
Somali
a0.0
10.0
20.0
30.0
40.0
50.0
60.0
50.9
15.6
9.56.9
3.7 3.6 3.5 3.2 2.1 1.90.6 0.6 0.6 0.4 0.4 0.3 0.2 0.2 0.2 0.1 0.0 0.0 0.0
Incidence of Rubella /million in EMR 2012
http://www.emro.who.int/entity/vpi/
Measles in Syria and the surrounding countries
Syrian camp in Lebanon
http://www.emro.who.int/entity/vpi/
0
20
40
60
80
100
120Ja
n-07
Apr-
07Ju
l-07
Oct
-07
Jan-
08Ap
r-08
Jul-0
8O
ct-0
8Ja
n-09
Apr-
09Ju
l-09
Oct
-09
Jan-
10Ap
r-10
Jul-1
0O
ct-1
0Ja
n-11
Apr-
11Ju
l-11
Oct
-11
Jan-
12Ap
r-12
Jul-1
2O
ct-1
2Ja
n-13
Apr-
13
2007 2008 2009 2010 2011 2012 2013
Monthly distribution of total measles cases, Syria 2007-2013
0
5
10
15
20
25
30
Jan-
07Ap
r-07
Jul-0
7O
ct-0
7Ja
n-08
Apr-
08Ju
l-08
Oct
-08
Jan-
09Ap
r-09
Jul-0
9O
ct-0
9Ja
n-10
Apr-
10Ju
l-10
Oct
-10
Jan-
11Ap
r-11
Jul-1
1O
ct-1
1Ja
n-12
Apr-
12Ju
l-12
Oct
-12
Jan-
13Ap
r-13
Jul-1
3
2007 2008 2009 2010 2011 2012 2013
Monthly distribution of total measles cases, Jordan 2007-2013
0
500
1000
1500
2000
2500
3000
Jan-
07
Apr-
07
Jul-0
7
Oct
-07
Jan-
08
Apr-
08
Jul-0
8
Oct
-08
Jan-
09
Apr-
09
Jul-0
9
Oct
-09
Jan-
10
Apr-
10
Jul-1
0
Oct
-10
Jan-
11
Apr-
11
Jul-1
1
Oct
-11
Jan-
12
Apr-
12
Jul-1
2
Oct
-12
Jan-
13
Apr-
13
2007 2008 2009 2010 2011 2012 2013
Monthly distribution of total measles cases, Iraq 2007-2013
0
100
200
300
400
500
600
700
Jan-
06Ap
r-06
Jul-0
6O
ct-0
6Ja
n-07
Apr-
07Ju
l-07
Oct
-07
Jan-
08Ap
r-08
Jul-0
8O
ct-0
8Ja
n-09
Apr-
09Ju
l-09
Oct
-09
Jan-
10Ap
r-10
Jul-1
0O
ct-1
0Ja
n-11
Apr-
11Ju
l-11
Oct
-11
Jan-
12Ap
r-12
Jul-1
2O
ct-1
2Ja
n-13
Apr-
13
2006 2007 2008 2009 2010 2011 2012 2013
Monthly distribution of total measles cases, Lebanon 2006-2013
http://www.emro.who.int/entity/vpi/
Efforts are ongoing to coordinate synchronized MCV SIAs in Syria
and surrounding countries
http://www.emro.who.int/entity/vpi/
SyriaActivities Completed Activities Planned
• March 2013– MMR SIAs for IDP
shelters (6 m - 15 y) – MMR SIAs for school
children 1st- 4th grade
• April 2013– MMR SIAs during the
regional vaccination week (1-5 y)
• 10-21 November 2013– MMR SIAs– 1-5y not reached in
previous SIAs
• MMR SIAs– School students– 6th – 9th grade
• Negotiation to implement SIAs for higher age group
http://www.emro.who.int/entity/vpi/
Jordan Activities Completed Activities Planned
• April 2013– M SIAs in Syrian refugee
camps– 6 m-30y– Coverage was not very high.
• On going M vaccination of new Syrian refugees – 6 m-30y
• July 2013– M SIAs in Irbid and Mafrak,
including the camps– almost 100% coverage
• 2-21 November 2013– Nationwide MR SIAs– 6m-20y
http://www.emro.who.int/entity/vpi/
Lebanon Activities Completed Activities Planned
• March 2013:– National M SIAs– including Syrian refugees– 9m-18y
• MMR vaccination of Syrian new comers
• Outbreak is still ongoing• EMRO recommendation
for elimination:– MR SIAs (9m-30y) – synchronized with
Jordan
• Under negotiation with MOH
http://www.emro.who.int/entity/vpi/
Iraq Activities Completed Activities Planned
• Refugee camps:– Vaccination with MMR
for age 6m-18y for refugee camps and surrounding community
– Vaccination of all new comers (6m-18y)
• Nation-wide preferable– or at least in most
affected provinces
• EMRO recommended– MR/MMR SIAs (6m-30y)
• Under discussion with MOH
http://www.emro.who.int/entity/vpi/
Challenges and barriers to achieving the target
• Security situation, refugees and displaced populations• Susceptible hard to reach populations groups
– Gypsy, resistant population, expatriate work forces• Measles among older age group
in almost all countries• Human Resources
- Inadequate technical and managerial capacity of national EPI programme - Rapid turn over of staff
• Inadequate data quality- High incidence of measles despite reported high coverage of routine and/or SIAs
coverage • Funding: specially for the follow-up campaigns
– FU campaigns needed in 7 countries– Measles surveillance
http://www.emro.who.int/entity/vpi/
Facing the challenges: 1. Routine strengthening and improving data quality
• Conduct EPI/measles programme reviews:– Afghanistan, Bahrain, Egypt, Jordan, Oman, Qatar, Kuwait, Pakistan, Saudi
Arabia, Sudan, Yemen, UAE• Strengthening implementation of RED approach
– Afghanistan, Iraq, Pakistan, Somalia, South Sudan, Sudan and Yemen• Training workshop on measles surveillance and monitoring and
evaluation of EPI with emphasis on data quality to improve routine immunization, January 2013
• Annual measles/rubella elimination meeting: reviewing performance and developing annual plans
• EPI-PEI collaboration in Pakistan: Using PEI assets to strengthen routine immunization
• WHO-CDC collaboration for strengthening routine immunization and data quality in Afghanistan, started August 2013
http://www.emro.who.int/entity/vpi/
Facing the challenges: 2. Advocacy and Communication
• Regional Director highlighting progress towards measles elimination at the Regional Committee
• Regional vaccination week 2013: Theme “Stop Measles Now” celebrated by all countries
• NITAG chairpersons attend annual measles/ rubella meeting
• Advocacy for allocation of national resources and targeting older age group– Pakistan, Morocco, Jordan, Lebanon SIAs in 2013
http://www.emro.who.int/entity/vpi/
SIAs and Fund requirement for SIAs 2013-2014
21
Country SIAs Surveillance
Funding gapVaccine Target age Target number Total cost in
US$
Afghanistan 2014
M 9-59M high risk dist.
1,500,0001,275,000 $154,375
$1,429,375
Somalia 2013M 9-59M
CHDs1,287,935 (accessible
areas)
2,610,000$91,000
None (if committed money is provided
Somalia 2014 M 9-59M 1,779,095 4,600,000 $148,000 $4,748,000Pakistan 2013 M 6M to 9Y 14,000,000 14,760,601 $100,000 $2,200,000Pakistan 2014 M 6M to 9Y 48,500,000 50,833,067 $100,000 $17,122,067Sudan 2013 M 9M-15Y 15,203,664 16,700,000 $150,000 $1,660,000Sudan 2014 M 0 0 0 $150,000 $150,000Yemen 2013 M
6M-10Y 304,527 (Sa'adah) 120,023 $260,000 $105,000
Yemen 2014 MR 6M-20Y 14,379,556 11,503,645 $368,000 $3,902,434Total 93,224,710 103,323,590 1,521,375 31,316,876
http://www.emro.who.int/entity/vpi/
Technical assistance needs in 2013-2014
22
• For all countries planning SIAs: strong consultants are needed to support planning, implementation and evaluation of the SIAs
http://www.emro.who.int/entity/vpi/
Thank You
23
http://www.emro.who.int/entity/vpi/
21y
23y 29y
13y